{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-017331","form_type":"8-K","ticker":"ADMA","cik":"0001368514","company_name":"ADMA BIOLOGICS, INC.","filed_at":"2024-04-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.112071+00:00","generated_at":"2026-06-04T03:25:02.046297+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"ADMA Biologics promotes Kaitlin Kestenberg to COO and SVP, Compliance","bullets":["Kestenberg promoted from SVP, Compliance & Project Operations to COO and SVP, Compliance, effective April 1, 2024.","Base salary of $460,000; annual target bonus of 50% of base salary.","Granted options for 300,328 shares and 192,320 RSUs, each vesting over four years.","Severance includes 12 months salary (or 15 months plus 1.5x bonus upon change of control) plus COBRA.","Kestenberg has been with ADMA since 2011; prior roles at Acorda Therapeutics and Merck."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-017331","json":"https://secwatch.observer/filing/0001140361-24-017331.json","markdown":"https://secwatch.observer/filing/0001140361-24-017331.md","text":"https://secwatch.observer/filing/0001140361-24-017331.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124017331/0001140361-24-017331-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124017331/ef20025617_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T03:25:02.046297+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e6950a83cf","claim":"Kaitlin Kestenberg changed role as Chief Operating Officer and Senior Vice President, Compliance at ADMA BIOLOGICS, INC..","evidence_excerpt":"Effective April 1, 2024 (the “Effective Date”), Kaitlin Kestenberg, former Senior Vice President, Compliance & Project Operations of ADMA Biologics, Inc. (the “Company”), was promoted to Chief Operating Officer and Senior Vice President, Compliance of the Company","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124017331/0001140361-24-017331-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"promoted"},{"label":"Role","value":"Chief Operating Officer and Senior Vice President, Compliance"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}